CD4 and breast carcinoma: In addition, a previous study found that IL25 expression in breast cancer was a positive correlation with infiltrating CD4+T cells and macrophages, whereas IL25 blockade decreased type 2 T cells and macrophages in the primary tumor microenvironments and inhibited lung metastasis (19).